Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024)
Atara Biotherapeutics (ATRA) reported Inventory Average of $12.3 million for Q4 2024, up 51.16% on a YoY basis from $8.1 million in Q1 2024, and down 24.73% quarter-over-quarter from $16.4 million in Q3 2024.
Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024) Analysis & Trends
Atara Biotherapeutics has reported Inventory Average for 2 years, with the latest figure at $12.3 million in Q4 2024.
- For the quarter ending Q4 2024, Inventory Average rose 51.16% year-over-year to $12.3 million; the trailing twelve-month figure through Dec 2024 stood at $12.3 million (up 51.16% YoY), and the FY2024 full-year result was $10.2 million, up 80.31% from the prior year.
- Inventory Average for Q4 2024 stood at $12.3 million, down from $16.4 million in the prior quarter.
- The five-year high for Inventory Average was $17.4 million in Q2 2024, with the low at $3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.46 Mn |